|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.706 SEK | +6.36% |
|
-22.81% | -33.88% |
| Apr. 13 | Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024. | CI |
| Apr. 12 | Biovica International AB Announces Divitum® Tka in Observational Trial | CI |
Biovica International AB (publ) reported earnings results for the full year ended April 30, 2023. For the full year, the company reported sales was SEK 4.96 million compared to SEK 5.04 million a year ago. Revenue was SEK 5.7 million compared to SEK 6.3 million a year ago.
Net loss was SEK 110.49 million compared to SEK 60 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -33.88% | 13.08M | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 377M |
BIOVICA INTERNATIONAL AB 
